Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Unraveling the PLTR Stock Decline – What's Behind the Plummet?

Palantir Technologies plummeted to $196.46 per share this afternoon, but it remains 26.92% above its mean target price of $154.79. There may still be room for more downwards movement — even after today's -1.2% drop. Analysts are giving the Large-Cap Software stock on average rating of hold, with target prices ranging from $45.0 to $215.0 per share.

The stock has an average amount of shares sold short at 2.2%, and a short ratio of 0.9. The company's insiders own 3.61% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that an average number of institutional investors are invested in the stock, with 57.4% of Palantir Technologies's shares being owned by this investor type.

Institutions Invested in Palantir Technologies

Date Reported Holder Percentage Shares Value
2025-06-30 Vanguard Group Inc 9% 205,717,666 $40,415,190,456
2025-06-30 Blackrock Inc. 8% 177,230,734 $34,818,661,948
2025-06-30 State Street Corporation 4% 94,481,128 $18,561,715,466
2025-06-30 Geode Capital Management, LLC 2% 49,704,870 $9,764,994,065
2025-06-30 Morgan Stanley 2% 32,948,594 $6,473,064,407
2025-06-30 NORGES BANK 1% 24,262,451 $4,766,589,069
2025-06-30 Invesco Ltd. 1% 20,585,256 $4,044,169,166
2025-06-30 Northern Trust Corporation 1% 20,319,224 $3,991,904,651
2025-06-30 FMR, LLC 1% 19,039,473 $3,740,485,406
2025-06-30 Goldman Sachs Group Inc 1% 17,887,465 $3,514,162,486

Besides an analyst belief that shares are overpriced, other market factors point to there being mixed market sentiment on Palantir Technologies.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS